A phase I-II study on intravesical gemcitabine in superficial bladder papillary tumors

被引：2
|
作者：
Serretta, V
Pavone, C
Galuffo, A
Dispensa, N
Vella, M
Caramia, M
Pavone-Macaluso, M
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37534-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] A PHASE II STUDY ON INTRAVESICAL GEMCITABINE IN SUPERFICIAL BLADDER CANCER
    Manfredi, V.
    Mattioli, F.
    Gosmar, M.
    Garbero, C.
    Martelli, A.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3503 - 3503
  • [2] Intravesical gemcitabine in superficial bladder cancer: a phase II safety, efficacy and pharmacokinetic study
    Mattioli, F
    Curotto, A
    Manfredi, V
    Gosmar, M
    Garbero, C
    Ambruosi, C
    Carmignani, G
    Martelli, A
    ANTICANCER RESEARCH, 2005, 25 (3C) : 2493 - 2496
  • [3] Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation
    De Berardinis, E
    Antonini, G
    Peters, GJ
    Loves, WJP
    van der Born, K
    Codacci-Pisanelli, G
    Di Silverio, F
    BJU INTERNATIONAL, 2004, 93 (04) : 491 - 494
  • [4] Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: A phase I and pharmacokinetic study
    Laufer, M
    Ramalingam, S
    Schoenberg, MP
    Haisfield-Wolf, ME
    Zuhowski, EG
    Trueheart, IN
    Eisenberger, MA
    Nativ, O
    Egorin, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 697 - 703
  • [5] PHASE-I PHASE-II TRIAL OF INTRAVESICAL METHOTREXATE FOR SUPERFICIAL BLADDER-TUMORS
    STERNBERG, CN
    YAGODA, A
    BANDER, NH
    WHITMORE, WF
    HUFFMAN, JL
    FLEISHER, M
    MELAMED, M
    FANUCCHI, MP
    HOLLANDER, P
    VAUGHAN, ED
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (03) : 265 - 269
  • [6] Intravesical administration of gemcitabine in superficial bladder cancer: A phase I study with pharmacodynamic evaluation. A phase II study with chemoresection of the marker lesion
    De Berardinis, E
    Antonini, G
    Gomez, AMA
    Pisanelli, GC
    Di Silverio, F
    Peters, GJ
    JOURNAL OF UROLOGY, 2004, 171 (04): : 72 - 72
  • [7] Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions
    Serretta, V
    Galuffo, A
    Pavone, C
    Allegro, R
    Pavone-Macaluso, M
    UROLOGY, 2005, 65 (01) : 65 - 69
  • [8] PHASE-I AND PHARMACOLOGY STUDY OF INTRAVESICAL MITOXANTRONE FOR RECURRENT SUPERFICIAL BLADDER-TUMORS
    STEWART, DJ
    GREEN, R
    FUTTER, N
    WALSH, W
    MCKAY, D
    VERMA, S
    MAROUN, JA
    REDMOND, D
    JOURNAL OF UROLOGY, 1990, 143 (04): : 714 - 716
  • [9] IDARUBICIN IN THE INTRAVESICAL TREATMENT OF SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE BLADDER (TA-T1) - A PHASE I-II STUDY
    SERRETTA, V
    PIAZZA, S
    VASILE, P
    PIAZZA, B
    ONCOLOGY REPORTS, 1995, 2 (06) : 1089 - 1092
  • [10] A phase II study of intravesical gemcitabine as adjuvant therapy in patients (pts) with superficial bladder carcinoma: final results
    Bounedjar, A.
    Ferhat, R.
    Bouzid, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 249 - 249
12345